MeSH tree: D06.472
People taking semaglutide for weight loss continued to consume significantly fewer calories after 60 weeks on the medication, helping explain how the medication supports both initial weight loss and long-term weight maintenance. ...
1 hour ago
0
0
In the 108-year history of daylight saving time in the United States, the country has moved three times to institute it year-round: during each of the two world wars and in 1973–74.
1 hour ago
0
0
Chronic, low-grade inflammation in the body—a phenomenon known as "inflammaging" because it increases with age—has been linked to many of today's leading causes of illness and death, including cancer, heart disease, metabolic ...
11 hours ago
0
2
Pregnant women who live in greener neighborhoods may have lower levels of long-term stress, according to a new study led by researchers from Bar-Ilan University. The study found that greater exposure to residential greenery ...
Jul 20, 2026
0
2
Social connections are known to contribute greatly to people's psychological and emotional well-being. In fact, difficulties socializing and bonding with others have been linked to various psychiatric conditions, including ...
An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—a type of medication that mimics the GLP-1 hormone—to lower blood sugar and support weight loss. Some research ...
Jul 17, 2026
0
5
Researchers at the University of California San Diego School of Medicine have reported results from a large international clinical trial showing that semaglutide, a medication in the GLP-1 class of drugs widely used to treat ...
Jul 17, 2026
0
8
Despite the end of federal shortages of popular GLP-1 weight-loss medications, the market for compounded alternatives remains strong—and some patients may unknowingly be receiving products from pharmacies with concerning ...
Jul 17, 2026
0
6
The popularity of GLP-1 drugs has created a new generation of body contouring patients and a new set of challenges for plastic surgeons.
Jul 16, 2026
0
6
Why do some people lose substantial weight with GLP-1-based medications while others see more modest results? A Mayo Clinic study offers a potential answer by identifying a distinct biological subtype of obesity that responds ...
Jul 16, 2026
0
5
